Canandaigua National Bank & Trust Co. Purchases Shares of 2,120 Encompass Health Corporation $EHC

Key Points

• Canandaigua National Bank & Trust Co. has purchased a new stake in Encompass Health Corporation, acquiring 2,120 shares valued at approximately $260,000.
• Encompass Health reported strong quarterly earnings, with $1.40 earnings per share, exceeding expectations and reflecting 12% year-over-year revenue growth.
• The company recently increased its quarterly dividend to $0.19 per share, marking a boost from the previous $0.17, which highlights its positive financial outlook.

Canandaigua National Bank & Trust Co. purchased a new stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,120 shares of the company's stock, valued at approximately $260,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. WPG Advisers LLC purchased a new stake in shares of Encompass Health in the first quarter worth about $27,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of Encompass Health by 749.0% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company's stock worth $42,000 after buying an additional 367 shares during the period. Arlington Trust Co LLC boosted its position in shares of Encompass Health by 22.9% in the first quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock worth $68,000 after buying an additional 125 shares during the period. Caitong International Asset Management Co. Ltd boosted its position in shares of Encompass Health by 19.0% in the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company's stock worth $73,000 after buying an additional 115 shares during the period. Finally, SVB Wealth LLC purchased a new stake in shares of Encompass Health in the first quarter worth about $84,000. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Stock Performance

EHC stock traded down $1.39 on Friday, reaching $123.94. The company's stock had a trading volume of 1,428,682 shares, compared to its average volume of 602,788. Encompass Health Corporation has a 52 week low of $87.85 and a 52 week high of $127.15. The company has a market capitalization of $12.48 billion, a P/E ratio of 24.25, a price-to-earnings-growth ratio of 2.17 and a beta of 0.92. The firm has a fifty day moving average of $118.12 and a two-hundred day moving average of $113.71. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.20 by $0.20. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The business had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same period in the prior year, the company posted $1.11 EPS. The business's revenue for the quarter was up 12.0% compared to the same quarter last year. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. As a group, analysts predict that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a $0.19 dividend. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. Encompass Health's dividend payout ratio is currently 13.31%.

Analysts Set New Price Targets

Several brokerages have recently weighed in on EHC. Truist Financial upped their target price on Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a research report on Thursday, August 14th. Wall Street Zen cut Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research note on Thursday, June 5th. KeyCorp boosted their price target on Encompass Health from $135.00 to $140.00 and gave the stock an "overweight" rating in a research note on Tuesday, September 16th. Finally, UBS Group boosted their price target on Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating and seven have issued a Buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $138.43.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the transaction, the executive vice president directly owned 18,846 shares of the company's stock, valued at approximately $2,329,177.14. This trade represents a 5.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 2.00% of the stock is owned by company insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.